Unveiling Spanlastics as a Novel Carrier for Drug Delivery: A Review

Title:Unveiling Spanlastics as a Novel Carrier for Drug Delivery: A Review

Volume: 12

Author(s): Dipanjan Karati, Swarupananda Mukherjee*Bhupendra Prajapati

Affiliation:

• Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata – Group of Institutions, 124, B.L Saha Road, Kolkata 700053, India

Abstract:

Innovative colloidal preparations that can alter the pharmacological properties of drugs have been made possible by the advancement of nanotechnology. Recent advances in the sciences of the nanoscale have led to the creation of new methods for treating illnesses. Developments in nanotechnology may lessen the side effects of medicine by using effective and regulated drug delivery methods. A promising drug delivery vehicle is spanlastics, an elastic nanovesicle that can transport a variety of drug compounds. Spanlastics have expanded the growing interest in many types of administrative pathways. Using this special type of vesicular carriers, medications intended for topical, nasal, ocular, and trans-ungual treatments are delivered to specific areas. Their elastic and malleable structure allows them to fit into skin pores, making them ideal for transdermal distribution. Spanlastic is composed of non-ionic surfactants or combinations of surfactants. Numerous studies have demonstrated how spanlastics significantly improve, drug bioavailability, therapeutic effectiveness, and reduce medication toxicity. The several vesicular systems, composition and structure of spanlastics, benefits of spanlastics over alternative drug delivery methods, and the process of drug penetration via skin are all summarized in this paper. Additionally, it provides an overview of the many medications that may be treated using spanlastic vesicles. The primary benefits of these formulations were associated with their surface properties, as a variety of proteins might be linked to the look. For instance, procedure assessment and gold nanoparticles were employed as biomarkers for different biomolecules, which included tumor label detection. Anticipate further advancements in the customization and combining of spanlastic vesicles with appropriate zeta potential to transport therapeutic compounds to specific areas for enhanced disease treatment.

Cite this article as:

Karati Dipanjan, Mukherjee Swarupananda*, Prajapati Bhupendra, Unveiling Spanlastics as a Novel Carrier for Drug Delivery: A Review, Pharmaceutical Nanotechnology 2024; 12 () . https://dx.doi.org/10.2174/0122117385286921240103113543